Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office

Eur J Cancer. 1995;31A(3):408-10. doi: 10.1016/0959-8049(94)00483-l.

Authors

S S Burtles¹, D R Newell, R E Henrar, T A Connors

Affiliation

¹ Cancer Research Campaign, Cambridge Terrace, London, U.K.

PMID: 7786609
DOI: 10.1016/0959-8049(94)00483-l

No abstract available

Publication types

Guideline

MeSH terms

Animals
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / toxicity*
Drug Administration Schedule
Mice
Rats
Research Design
Toxicity Tests / methods*

Substances

Antineoplastic Agents